Atria Investments Inc Sells 526 Shares of Humana Inc. $HUM

Atria Investments Inc reduced its stake in Humana Inc. (NYSE:HUM) by 12.1% in the second quarter, HoldingsChannel reports. The institutional investor owned 3,808 shares of the insurance provider’s stock after selling 526 shares during the quarter. Atria Investments Inc’s holdings in Humana were worth $931,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Hantz Financial Services Inc. increased its stake in Humana by 457.7% during the 2nd quarter. Hantz Financial Services Inc. now owns 541 shares of the insurance provider’s stock valued at $132,000 after purchasing an additional 444 shares in the last quarter. New York Life Investment Management LLC grew its holdings in shares of Humana by 0.5% during the second quarter. New York Life Investment Management LLC now owns 18,078 shares of the insurance provider’s stock valued at $4,420,000 after buying an additional 98 shares during the last quarter. Teacher Retirement System of Texas increased its position in shares of Humana by 161.7% during the second quarter. Teacher Retirement System of Texas now owns 56,286 shares of the insurance provider’s stock valued at $13,761,000 after acquiring an additional 34,776 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Humana in the 2nd quarter worth approximately $1,523,000. Finally, Bessemer Group Inc. raised its holdings in Humana by 11.2% in the 2nd quarter. Bessemer Group Inc. now owns 1,983 shares of the insurance provider’s stock worth $485,000 after acquiring an additional 199 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research analyst reports. Wall Street Zen lowered Humana from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Bank of America increased their price target on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. The Goldman Sachs Group assumed coverage on Humana in a research report on Tuesday, October 14th. They set a “sell” rating and a $235.00 target price for the company. Piper Sandler decreased their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a report on Thursday, July 31st. Finally, Morgan Stanley decreased their target price on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $299.22.

Humana Stock Up 0.1%

Humana stock opened at $251.46 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The stock’s fifty day moving average is $278.04 and its two-hundred day moving average is $258.89. The stock has a market cap of $30.24 billion, a PE ratio of 19.30, a P/E/G ratio of 1.71 and a beta of 0.42. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same period last year, the firm earned $4.16 EPS. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. On average, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.4%. Humana’s dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.